2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparibovarian carcinosarcomaRecruitingPhase 2 / Phase 32026-09-09NCT03651206
A MULTICENTER, SEEKING SIGNAL, RANDOMISED, OPEN-LABEL PHASE II OF RELATLIMAB AND NIVOLUMAB VS NIVOLUMAB ALONE IN LOCALLY ADVANCED CERVICAL CANCERSLOCALLY ADVANCED CERVICAL CANCERSActive, not recruitingPhase 22026-07-30NCT06715241